BrainsWay Ltd.

Equities

BWAY

IL0011007189

Advanced Medical Equipment & Technology

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 08:49:41 2024-06-02 EDT			5-day change	1st Jan Change
1,147 ^ILa	+5.23%		+13.90%	-0.17%

05-09	Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	MT
05-09	HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	MT

BrainsWay Ltd. Broadens Partnership with Katie?s Way Plus Through Order of an Additional 18 Deep TMS? Systems

March 18, 2024 at 07:30 am

BrainsWay Ltd. announced that its existing partner, Katie's Way Plus has ordered an additional 18 Deep Transcranial Magnetic Stimulation (Deep TMS?) systems. Katie?s Way Plus will now grow to an extensive network of approximately 40 Deep TMS systems.

Latest news about BrainsWay Ltd.

Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	05-09	MT
HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	05-09	MT
Transcript : BrainsWay Ltd., Q1 2024 Earnings Call, May 08, 2024	05-08
BrainsWay Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-08	CI
BrainsWay Ltd. Reiterates Revenue Guidance for the Year 2024	05-08	CI
Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates	04-17	CI
BrainsWay Ltd. Announces Publish Review Results Highlighting Potential of Deep Transcranial Magnetic Stimulation (Deep TMS?) as a Novel Therapeutic Approach for Parkinson's Disease	04-04	CI
Brainsway Announces Positive Results in Late-Life Depression Post-Marketing Analysis	03-28	CI
BrainsWay Ltd. Broadens Partnership with Katie?s Way Plus Through Order of an Additional 18 Deep TMS? Systems	03-18	CI
Transcript : BrainsWay Ltd., Q4 2023 Earnings Call, Mar 06, 2024	03-06
BrainsWay Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-06	CI
BrainsWay Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-06	CI
Brainsway Ltd. Provides Earnings Guidance for Full Year 2024	03-06	CI
BrainsWay Ltd. Announces New Rotational Field Technology in Two New Feasibility Studies	01-10	CI
Brainsway Expands Deep Transcranial Magnetic Stimulation Technology in South Korea	12-07	MT
BrainsWay Ltd. Announces Continued Expansion of Deep TMS in South Korea	12-07	CI
Brainsway Says Blue Cross Blue Shield of Louisiana Expands Access to Mental-Health Technology	11-20	MT
Oppenheimer Adjusts Price Target on Brainsway to $6 From $5.50, Maintains Outperform Rating	11-16	MT
Raymond James Downgrades Brainsway to Market Perform From Outperform	11-16	MT
Transcript : BrainsWay Ltd., Q3 2023 Earnings Call, Nov 15, 2023	11-15
Earnings Flash (BWAY) BRAINSWAY Reports Q3 Revenue $8.3M	11-15	MT
BrainsWay Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15	CI
BrainsWay Ltd. Announces Publishes the First Coverage Recommendations for Smoking Addiction Treatment Using TMS	11-02	CI
BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression	23-10-16	CI
Brainsway Receives 10 Orders for Deep Transcranial Magnetic Stimulation	23-09-20	MT

Chart BrainsWay Ltd.

Duration

Period

More charts

Company Profile

Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-06 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BRAINSWAY LTD.	-0.17%	97.75M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B

Other Advanced Medical Equipment & Technology